InsiderClue
Stocks · Health care · Services-Offices & Clinics of Doctors of Medicine

Starling Oncology, Inc.

STLN Clue Score47
United States Fiscal year ends December CIK 0001799191
$6.92 +4.37% Close, 12 Oct 2026
Alert on the numbers Alert on insider trades
Price $6.92 +361.33% Close, 12 Oct 2026

Closing prices at the end of each trading day, from 15 Nov 2021. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2020Revenue187.5Operating income−8.2Net income−14.3EPS, diluted−0.24Fiscal year 2021Revenue203.0 +8.3%Operating income−45.9Net income−10.9EPS, diluted−0.16Fiscal year 2022Revenue252.5 +24.4%Operating income−82.0Net income0.2EPS, diluted−0.21Fiscal year 2023Revenue324.2 +28.4%Operating income−77.0Net income−83.1 −54,750.0%EPS, diluted−0.92Fiscal year 2024Revenue393.4 +21.3%Operating income−60.1Net income−64.7EPS, diluted−0.71Fiscal year 2025Revenue502.7 +27.8%Operating income−36.1Net income−60.6EPS, diluted−0.54
FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 187.5 203.0 252.5 324.2 393.4 502.7
Growth +8.3% +24.4% +28.4% +21.3% +27.8%
Operating income −8.2 −45.9 −82.0 −77.0 −60.1 −36.1
Net income −14.3 −10.9 0.2 −83.1 −64.7 −60.6
Growth −54,750.0%
EPS, diluted −0.24 −0.16 −0.21 −0.92 −0.71 −0.54
Growth

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2020Operating margin−4.4%Net margin−7.6%Free cash flow margin−0.4%Fiscal year 2021Operating margin−22.6%Net margin−5.4%Free cash flow margin−17.5%Fiscal year 2022Operating margin−32.5%Net margin0.1%Free cash flow margin−26.6%Fiscal year 2023Operating margin−23.8%Net margin−25.6%Free cash flow margin−12.6%Fiscal year 2024Operating margin−15.3%Net margin−16.4%Free cash flow margin−7.7%Fiscal year 2025Operating margin−7.2%Net margin−12.1%Free cash flow margin−5.5%
FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin −4.4% −22.6% −32.5% −23.8% −15.3% −7.2%
Net margin −7.6% −5.4% 0.1% −25.6% −16.4% −12.1%
Free cash flow margin −0.4% −17.5% −26.6% −12.6% −7.7% −5.5%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2020Operating cash flow0.5Capital expenditure−1.2Free cash flow−0.7Fiscal year 2021Operating cash flow−32.7Capital expenditure−2.8Free cash flow−35.5Buybacks0.0Fiscal year 2022Operating cash flow−61.8Capital expenditure−5.5Free cash flow−67.3Buybacks−9.0Fiscal year 2023Operating cash flow−36.3Capital expenditure−4.6Free cash flow−40.9Buybacks−1.0Fiscal year 2024Operating cash flow−26.5Capital expenditure−3.8Free cash flow−30.3Buybacks0.0Fiscal year 2025Operating cash flow−24.6Capital expenditure−3.2Free cash flow−27.8
FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow 0.5 −32.7 −61.8 −36.3 −26.5 −24.6
Capital expenditure −1.2 −2.8 −5.5 −4.6 −3.8 −3.2
Free cash flow −0.7 −35.5 −67.3 −40.9 −30.3 −27.8
Growth
Buybacks n/a 0.0 −9.0 −1.0 0.0 n/a

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2020Cash0.9Total debt11.9Net cash (debt)−11.0Shareholders’ equity28.1Debt to equity0.42Fiscal year 2021Cash115.2Total debt0.2Net cash (debt)115.0Shareholders’ equity104.2Debt to equity0.00Fiscal year 2022Cash14.0Total debt80.6Net cash (debt)−66.6Shareholders’ equity123.2Debt to equity0.65Fiscal year 2023Cash33.5Total debt86.8Net cash (debt)−53.3Shareholders’ equity57.0Debt to equity1.52Fiscal year 2024Cash49.7Total debt93.1Net cash (debt)−43.5Shareholders’ equity3.6Debt to equity25.95Fiscal year 2025Cash33.6Total debt77.4Net cash (debt)−43.8Shareholders’ equity−15.7
FY2020FY2021FY2022FY2023FY2024FY2025
Cash 0.9 115.2 14.0 33.5 49.7 33.6
Total debt 11.9 0.2 80.6 86.8 93.1 77.4
Net cash (debt) −11.0 115.0 −66.6 −53.3 −43.5 −43.8
Shareholders’ equity 28.1 104.2 123.2 57.0 3.6 −15.7
Debt to equity 0.42 0.00 0.65 1.52 25.95 n/a

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Balance sheet

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Assets
0.9 115.2 14.0 33.5 49.7 33.6
17.1 20.0 39.8 42.4 48.3 59.0
4.4 6.4 9.3 13.7 10.0 16.9
2.1 4.2 8.5 10.9 11.9 10.7
14.2 26.6 21.4 7.2 7.2 7.2
65.7 203.4 261.7 209.2 172.7 164.7
Growth +209.7% +28.6% −20.0% −17.5% −4.7%
Liabilities
5.4 0.2 0.0 n/a n/a n/a
6.6 0.0 80.6 86.8 93.1 77.4
calc 11.9 0.2 80.6 86.8 93.1 77.4
37.6 99.3 138.5 152.2 169.1 180.4
Equity
−52.3 −63.2 −63.1 −146.2 −210.8 −271.4
28.1 104.2 123.2 57.0 3.6 −15.7
Growth +270.7% +18.3% −53.7% −93.7% −538.0%
Per share and net cash
calc −11.0 115.0 −66.6 −53.3 −43.5 −43.8
5.8 73.2 73.3 74.1 75.7 98.9
calc 4.89 1.42 1.68 0.77 0.05 −0.16

Lines marked calc are worked out here from filed figures; point at one for how.